Total raised
$1.0M
Last: Pre-Seed 2024-04
Stage
Pre-Seed
Founded
2024
Headcount
7
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences
About
Tracells specializes in non-invasive diagnostic testing for inflammatory bowel diseases (IBD) using advanced RNA transcriptomics and AI-driven classifiers. Their stool tests utilize RNA profiles from intestinal cells to accurately diagnose IBD, assess inflammation severity and location, and predict therapy response. This method aims to replace invasive procedures like endoscopies with a convenient, home-based testing alternative, offering precise, cost-effective monitoring and disease management.
Funding history · 1 round · $1.0M total
2024-04
Pre-Seed
$1.0M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Tracells founded?
- Tracells was founded in January 2024.
- What is Tracells' primary focus?
- Tracells specializes in non-invasive diagnostic testing for inflammatory bowel diseases (IBD) using advanced RNA transcriptomics and AI-driven classifiers.
- What type of product does Tracells offer for IBD diagnosis?
- Tracells offers stool tests that utilize RNA profiles from intestinal cells to diagnose IBD, assess inflammation, and predict therapy response.
- What is the total amount of funding Tracells has raised to date?
- Tracells has raised a total of $1,000,000 USD.
- When did Tracells complete its Pre-Seed funding round and who was an investor?
- Tracells completed its Pre-Seed funding round in April 2024, with G.O Innovation as an investor.
- Has Tracells received any grants?
- Yes, Tracells received a grant from the IIA in April 2024.
- What is the current employee count for Tracells?
- Tracells currently has 7 employees.
- What is Tracells' current product stage?
- Tracells' product is currently in the clinical trial stage.
- Who are the founders of Tracells?
- The founders of Tracells are Maya Hanum and Yotam Harnik.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
pharmaceuticalsnon-invasivediagnosticsinflammatory-diseases